Cases & Deals

Akebia defends patent for prolyl hydroxylase inhibitors before European Patent Office

Clients Akebia Therapeutics, Inc.

Jones Day advises Akebia Therapeutics, Inc. on defending a patent covering prolyl hydroxylase inhibitors before the European Patent Office.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.